Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Radionics, headquartered in Burlington, Massachusetts, USA, is a developer of products in the fields of neurosurgery and radiation therapy. Founded in 1938, Radionics became a division of Tyco Healthcare in January 2000.

Radionics' principal products include:

The CRW stereotactic system for brain biopsies and electrode placement.
The CUSA EXcel ultrasonic surgical aspiration system for tumour removal and other surgical procedures.
The OmniSight EXcel image guidance system for interactive computer guidance during surgery.
The XKnife stereotactic radiosurgery and radiotherapy system for the irradiation of cancer.

In North America, Radionics employs 150 sales professionals covering 26 geographic regions. While the US remains Radionics' dominant market, a substantial portion of the company's sales are generated in the international market. Radionics has a growing infrastructure in Europe, Asia and South America. In total, Radionics has approximately 350 direct and indirect employees worldwide.